Clarus Group, Inc. Harrow Health, Inc. Transaction History
Clarus Group, Inc.
- $273 Million
- Q3 2025
A detailed history of Clarus Group, Inc. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Clarus Group, Inc. holds 5,000 shares of HROW stock, worth $181,850. This represents 0.09% of its overall portfolio holdings.
Number of Shares
5,000Holding current value
$181,850% of portfolio
0.09%Shares
5 transactions
Others Institutions Holding HROW
# of Institutions
190Shares Held
21.9MCall Options Held
390KPut Options Held
413K-
Opaleye Management Inc. Boston, MA3.91MShares$142 Million28.52% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$78.1 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.95MShares$70.8 Million6.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$68 Million0.0% of portfolio
-
Braidwell LP Stamford, CT872KShares$31.7 Million1.63% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $985M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...